187 related articles for article (PubMed ID: 7985122)
21. Our first experience of transfusion support in allogenic bone marrow transplantations.
Fregatova L; Volkova O; Platonova G; Afanasiev B
Beitr Infusionsther Transfusionsmed; 1994; 32():445-7. PubMed ID: 9422124
[TBL] [Abstract][Full Text] [Related]
22. Long-term cryopreservation of bone marrow for autologous transplantation.
Attarian H; Feng Z; Buckner CD; MacLeod B; Rowley SD
Bone Marrow Transplant; 1996 Mar; 17(3):425-30. PubMed ID: 8704699
[TBL] [Abstract][Full Text] [Related]
23. Techniques to reduce breakage of frozen stem cell products.
Hubbell CA; Tormey LJ; Snyder RA; Mignot LO; Zamkoff KA; Dracker RA
Prog Clin Biol Res; 1994; 389():663-6. PubMed ID: 7700934
[No Abstract] [Full Text] [Related]
24. Stem cell transfusion from long-term marrow culture.
Charbord P
Transfus Sci; 1992; 13(4):407-13. PubMed ID: 10150139
[No Abstract] [Full Text] [Related]
25. Purging: elimination of malignant cells from autologous blood or marrow transplants.
Champlin R
Curr Opin Oncol; 1996 Mar; 8(2):79-83. PubMed ID: 8727298
[No Abstract] [Full Text] [Related]
26. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
[TBL] [Abstract][Full Text] [Related]
27. Purging of autologous bone marrow in the treatment of non-Hodgkin's lymphoma.
Gribben JG; Nadler LM
Important Adv Oncol; 1993; ():139-56. PubMed ID: 8505048
[No Abstract] [Full Text] [Related]
28. [Effect of cryopreservation of bone marrow stromal cells on periodontal tissue regeneration].
Li HX; Yan FH; Lei L; Liu JG
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Apr; 43(4):246-7. PubMed ID: 18846951
[TBL] [Abstract][Full Text] [Related]
29. Cryopreservation of marrow cells for ABMT. Is there any effect on the harvested leukaemic cells?
Alessandrino EP; Bernasconi P; Lazzarino M; Castelli G; Bonfichi M; Caldera D; Colombo A; Boni M; Bernasconi C
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():81-4. PubMed ID: 2697444
[No Abstract] [Full Text] [Related]
30. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow transplantation with major ABO blood group incompatibility using automated removal of red blood cells from incompatible bone marrow by CS 3000 plus.
O-Charoen R; Soiprasert P; Chaisiripoomkere W; Jootar S; Chiewsilp P
Transplant Proc; 1994 Aug; 26(4):2352-3. PubMed ID: 8066772
[No Abstract] [Full Text] [Related]
32. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
Geller RB
Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
[TBL] [Abstract][Full Text] [Related]
33. Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.
Letheby B; Jackson J; Greally J; Warkentin P; Smith D; Vose J; Bierman P; Kessinger A; Coccia P; Armitage J
Prog Clin Biol Res; 1992; 377():345-51. PubMed ID: 1279712
[No Abstract] [Full Text] [Related]
34. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
35. Use of gene marking in bone marrow transplantation.
Heslop HE; Rooney CM; Rill DR; Krance RA; Brenner MK
Cancer Detect Prev; 1996; 20(2):108-13. PubMed ID: 8706035
[TBL] [Abstract][Full Text] [Related]
36. Analgesic infiltration at the site of bone marrow harvest significantly reduces donor morbidity.
Chern B; McCarthy N; Hutchins C; Durrant ST
Bone Marrow Transplant; 1999 May; 23(9):947-9. PubMed ID: 10338052
[TBL] [Abstract][Full Text] [Related]
37. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
38. Autologous bone marrow support and bone disease in metastatic breast cancer.
Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
[TBL] [Abstract][Full Text] [Related]
39. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation.
Guttridge MG; Sidders C; Booth-Davey E; Pamphilon D; Watt SM
Bone Marrow Transplant; 2006 Aug; 38(3):175-81. PubMed ID: 16770313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
